The revision of Guidelines for Clinical Evaluation Methods of Anti-Cancer Drugs in Japan

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 33, Issue 7, 2006, Pages 1015-1019

  Andoh, Masashi ^a   Fujiwara, Yasuhiro ^a   Shimada, Yasuhiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CLINICAL TRIAL; EVALUATION; HUMAN; JAPAN; METHODOLOGY; NEOPLASM; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRACTICE GUIDELINE; STANDARD;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; EVALUATION STUDIES; HUMANS; JAPAN; NEOPLASMS; PRACTICE GUIDELINES;

EID: 33746754235     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)